Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
$993K Hold
14,672
1.78% 17
2018
Q2
$850K Sell
14,672
-37,728
-72% -$2.13M 1.6% 21
2018
Q1
$2.72M Hold
52,400
3.66% 14
2017
Q4
$2.81M Hold
52,400
3.51% 14
2017
Q3
$3.2M Buy
+52,400
New +$3.18M 3.17% 21
2017
Q2
Sell
-54,077
Closed -$3.28M 33
2017
Q1
$3.28M Hold
54,077
3.39% 16
2016
Q4
$3.04M Buy
+54,077
New +$3.16M 3.22% 20

Other funds holding MRK

Hampstead Capital's MRK Position: Q3 2018 in Review

Hampstead Capital held its Merck (MRK) position steady in Q3 2018 at 14,672 shares worth $993K. The position accounts for 1.78% of the portfolio, ranked #17.

Hampstead Capital first reported a position in MRK in Q4 2016 and has held it in 7 quarters since. The position peaked at $3.28M in Q1 2017. 2,057 funds tracked by Wall St. Rank hold MRK as of Q3 2018.

  • Hampstead Capital held 14,672 shares of Merck worth $993K as of Q3 2018.
  • Hampstead Capital left its Merck share count unchanged in Q3 2018.
  • Merck made up 1.78% of Hampstead Capital's portfolio in Q3 2018, its #17 holding.
  • Hampstead Capital first reported a position in Merck in Q4 2016 and has held it in 7 quarters since.
  • Hampstead Capital's Merck position peaked at $3.28M in Q1 2017.
  • 2,057 funds tracked by Wall St. Rank held Merck as of Q3 2018.

Based on Hampstead Capital's 13F filing for Q3 2018, filed 14 Nov 2018.